BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shim KY, Eom YW, Kim MY, Kang SH, Baik SK. Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension. Korean J Intern Med. 2018;33:453-461. [PMID: 29462546 DOI: 10.3904/kjim.2017.317] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Danoy M, Tauran Y, Poulain S, Jellali R, Bruce J, Leduc M, Le Gall M, Gilard F, Kido T, Arakawa H, Araya K, Mori D, Kato Y, Kusuhara H, Plessy C, Miyajima A, Sakai Y, Leclerc E. Multi-omics analysis of hiPSCs-derived HLCs matured on-chip revealed patterns typical of liver regeneration. Biotechnol Bioeng 2021. [PMID: 33404112 DOI: 10.1002/bit.27667] [Reference Citation Analysis]
2 Jung MH, Lee JH, Lee CJ, Shin JH, Kang SH, Kwon CH, Kim DH, Kim WH, Kim HL, Kim HM, Cho IJ, Cho I, Hwang J, Ryu S, Kang C, Lee HY, Chung WJ, Ihm SH, Kim KI, Cho EJ, Sohn IS, Park S, Shin J, Ryu SK, Rhee MY, Kang SM, Pyun WB, Cho MC, Sung KC. Effect of angiotensin receptor blockers on the development of cancer: A nationwide cohort study in korea. J Clin Hypertens (Greenwich) 2021;23:879-87. [PMID: 33492766 DOI: 10.1111/jch.14187] [Reference Citation Analysis]
3 Pong LY, Parkkinen S, Dhanoa A, Gan HM, Wickremesinghe IAC, Syed Hassan S. MicroRNA profiling of mouse liver in response to DENV-1 infection by deep sequencing. PeerJ 2019;7:e6697. [PMID: 31065454 DOI: 10.7717/peerj.6697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Shu Y, Cao X, Chen J. Preparation and antagonistic effect of ACE inhibitory peptide from cashew. J Sci Food Agric 2019;99:6822-32. [DOI: 10.1002/jsfa.9967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Møller S, Kimer N, Barløse M, Bendtsen F. Pathophysiological-based treatments of complications of cirrhosis. Scand J Gastroenterol 2020;55:383-94. [PMID: 32233873 DOI: 10.1080/00365521.2020.1744709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Yang C, Wu X, Shen Y, Liu C, Kong X, Li P. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway. Eur J Pharmacol 2020;883:173384. [PMID: 32707188 DOI: 10.1016/j.ejphar.2020.173384] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
7 Nehme A, Zouein FA, Zayeri ZD, Zibara K. An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology.J Cardiovasc Dev Dis. 2019;6. [PMID: 30934934 DOI: 10.3390/jcdd6020014] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 22.7] [Reference Citation Analysis]
8 Cabrera D, Rao I, Raasch F, Solis N, Pizarro M, Freire M, Sáenz De Urturi D, Ramírez CA, Triantafilo N, León J, Riquelme A, Barrera F, Baudrand R, Aspichueta P, Arrese M, Arab JP. Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice. Ann Hepatol 2021;24:100357. [PMID: 33940220 DOI: 10.1016/j.aohep.2021.100357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Abrahamovych M, Abrahamovych O, Fayura O, Tolopko S. Relation between redox homeostasis blood parameters in cirrhotic patients and endothelial dysfunction development. Minerva Gastroenterol Dietol 2020;66:98-105. [PMID: 32218418 DOI: 10.23736/S1121-421X.20.02654-9] [Reference Citation Analysis]
10 Khanam A, Saleeb PG, Kottilil S. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured? Cells 2021;10:1097. [PMID: 34064375 DOI: 10.3390/cells10051097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Elkhalifa D, Rayan M, Negmeldin AT, Elhissi A, Khalil A. Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases. Biomed Pharmacother 2022;145:112385. [PMID: 34915673 DOI: 10.1016/j.biopha.2021.112385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kang SH, Kim MY, Eom YW, Baik SK. Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives. Gut Liver 2020;14:306-15. [PMID: 31581387 DOI: 10.5009/gnl18412] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 22.0] [Reference Citation Analysis]
13 Abid A, Khan MA, Lee B, White A, Carnt N, Arshad S, Samarawickrama C, Anand V. Ocular Distribution of the Renin-Angiotensin-Aldosterone System in the Context of the SARS-CoV-2 Pandemic. Journal of the Renin-Angiotensin-Aldosterone System 2022;2022:1-9. [DOI: 10.1155/2022/9970922] [Reference Citation Analysis]
14 Gupta H, Youn GS, Han SH, Shin MJ, Yoon SJ, Han DH, Lee NY, Kim DJ, Baik SK, Suk KT. Response-Related Factors of Bone Marrow-Derived Mesenchymal Stem Cells Transplantation in Patients with Alcoholic Cirrhosis. J Clin Med 2019;8:E862. [PMID: 31212896 DOI: 10.3390/jcm8060862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Sansoè G, Aragno M, Wong F. Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver disease. Liver Int 2020;40:18-31. [PMID: 31580514 DOI: 10.1111/liv.14272] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
16 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Pryymachuk G, El-Awaad E, Piekarek N, Drebber U, Maul AC, Hescheler J, Wodarz A, Pfitzer G, Neiss WF, Pietsch M, Schroeter MM. Angiotensin II type 1 receptor localizes at the blood-bile barrier in humans and pigs. Histochem Cell Biol 2022. [PMID: 35229169 DOI: 10.1007/s00418-022-02087-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Philips CA, Kakkar K, Joseph M, Yerol PK, Ahamed R, Rajesh S, Augustine P. Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care. J Clin Transl Hepatol 2021;9:576-86. [PMID: 34447688 DOI: 10.14218/JCTH.2020.00110] [Reference Citation Analysis]
19 Li H. Intercellular crosstalk of liver sinusoidal endothelial cells in liver fibrosis, cirrhosis and hepatocellular carcinoma. Dig Liver Dis 2021:S1590-8658(21)00375-3. [PMID: 34344577 DOI: 10.1016/j.dld.2021.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Tavakkoli M, Aali S, Khaledifar B, Ferns GA, Khazaei M, Fekri K, Arjmand MH. The Potential Association between the Risk of Post-Surgical Adhesion and the Activated Local Angiotensin II Type 1 Receptors: Need for Novel Treatment Strategies. Gastrointest Tumors 2021;8:107-14. [PMID: 34307308 DOI: 10.1159/000514614] [Reference Citation Analysis]
21 Fernandes RS, Neto MRT, Carvalho FB, Rigatto K. ALAMANDINE: A PROMISING TREATMENT FOR FIBROSIS. Peptides 2022;:170848. [PMID: 35931236 DOI: 10.1016/j.peptides.2022.170848] [Reference Citation Analysis]
22 Qu L, Chen C, Yin T, Fang Q, Hong Z, Zhou R, Tang H, Dong H. ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review. Int J Mol Sci 2021;22:11483. [PMID: 34768911 DOI: 10.3390/ijms222111483] [Reference Citation Analysis]
23 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41:20-32. [PMID: 33190346 DOI: 10.1111/liv.14730] [Cited by in Crossref: 36] [Cited by in F6Publishing: 46] [Article Influence: 18.0] [Reference Citation Analysis]
24 Mastoor Z, Diz-chaves Y, González-matías LC, Mallo F. Renin–Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins. Metabolites 2022;12:411. [DOI: 10.3390/metabo12050411] [Reference Citation Analysis]
25 Graus-Nunes F, Santos FO, Marinho TS, Miranda CS, Barbosa-da-Silva S, Souza-Mello V. Beneficial effects of losartan or telmisartan on the local hepatic renin-angiotensin system to counter obesity in an experimental model. World J Hepatol 2019; 11(4): 359-369 [PMID: 31114640 DOI: 10.4254/wjh.v11.i4.359] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
26 Chaney A. Obesity and Nonalcoholic Fatty Liver Disease. Nurs Clin North Am 2021;56:543-52. [PMID: 34749893 DOI: 10.1016/j.cnur.2021.07.009] [Reference Citation Analysis]
27 Song H, Ren J. Protocatechuic acid attenuates angiotensin II‐induced cardiac fibrosis in cardiac fibroblasts through inhibiting the NOX4/ROS/p38 signaling pathway. Phytotherapy Research 2019;33:2440-7. [DOI: 10.1002/ptr.6435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
28 Olsavszky V, Sticht C, Schmid CD, Winkler M, Wohlfeil SA, Olsavszky A, Schledzewski K, Géraud C, Goerdt S, Leibing T, Koch PS. Exploring the transcriptomic network of multi-ligand scavenger receptor Stabilin-1- and Stabilin-2-deficient liver sinusoidal endothelial cells. Gene 2021;768:145284. [PMID: 33130055 DOI: 10.1016/j.gene.2020.145284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Romão MH, de Bem GF, Santos IB, de Andrade Soares R, Ognibene DT, de Moura RS, da Costa CA, Resende ÂC. Açaí (Euterpe oleracea Mart.) seed extract protects against hepatic steatosis and fibrosis in high-fat diet-fed mice: Role of local renin-angiotensin system, oxidative stress and inflammation. Journal of Functional Foods 2020;65:103726. [DOI: 10.1016/j.jff.2019.103726] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Guo YC, Lu LG. Antihepatic Fibrosis Drugs in Clinical Trials. J Clin Transl Hepatol 2020;8:304-12. [PMID: 33083254 DOI: 10.14218/JCTH.2020.00023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
31 Norambuena-Soto I, Lopez-Crisosto C, Martinez-Bilbao J, Hernandez-Fuentes C, Parra V, Lavandero S, Chiong M. Angiotensin-(1-9) in hypertension. Biochem Pharmacol 2022;:115183. [PMID: 35870482 DOI: 10.1016/j.bcp.2022.115183] [Reference Citation Analysis]
32 Mostafa TM, El-Azab GA, Badra GA, Abdelwahed AS, Elsayed AA. Effect of Candesartan and Ramipril on Liver Fibrosis in Patients with Chronic Hepatitis C Viral Infection: A Randomized Controlled Prospective Study. Curr Ther Res Clin Exp 2021;95:100654. [PMID: 34925649 DOI: 10.1016/j.curtheres.2021.100654] [Reference Citation Analysis]
33 Abreu Diaz AM, Drumeva GO, Laporte P, Alonso Martinez LM, Petrenyov DR, Carrier JF, DaSilva JN. Evaluation of the high affinity [18F]fluoropyridine-candesartan in rats for PET imaging of renal AT1 receptors. Nucl Med Biol 2021;96-97:41-9. [PMID: 33798796 DOI: 10.1016/j.nucmedbio.2021.03.003] [Reference Citation Analysis]
34 Bilgin BO, Sunbul M, Kani HT, Demirtas CO, Keklikkiran C, Yilmaz Y. Arterial stiffness is associated independently with liver stiffness in biopsy-proven nonalcoholic fatty liver disease: a transient elastography study. Eur J Gastroenterol Hepatol 2020;32:54-7. [PMID: 31290769 DOI: 10.1097/MEG.0000000000001471] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
35 Kim I, Park CS, Lee HY. Angiotensin II Type 1 Receptor Blocker, Fimasartan, Reduces Vascular Smooth Muscle Cell Senescence by Inhibiting the CYR61 Signaling Pathway. Korean Circ J 2019;49:615-26. [PMID: 31074217 DOI: 10.4070/kcj.2018.0379] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
36 Kitagawa N, Hashimoto Y, Hamaguchi M, Osaka T, Fukuda T, Yamazaki M, Fukui M. Liver Stiffness Is Associated With Progression of Albuminuria in Adults With Type 2 Diabetes: Nonalcoholic Fatty Disease Cohort Study. Can J Diabetes 2020;44:428-33. [PMID: 32616276 DOI: 10.1016/j.jcjd.2020.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Lelis DDF, Freitas DFD, Machado AS, Crespo TS, Santos SHS. Angiotensin-(1-7), Adipokines and Inflammation. Metabolism 2019;95:36-45. [DOI: 10.1016/j.metabol.2019.03.006] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 17.0] [Reference Citation Analysis]
38 Xu ZW, Liu NN, Wang XY, Ding BC, Zhang HF, Li Y, Sun WY, Wei W. Effect of PLC-β1/CaM signaling pathway mediated by AT1R on the occurrence and development of hepatocellular carcinoma. Cancer Cell Int 2021;21:587. [PMID: 34727945 DOI: 10.1186/s12935-021-02261-8] [Reference Citation Analysis]
39 Baig S, Paisey R, Dawson C, Barrett T, Maffei P, Hodson J, Rambhatla SB, Chauhan P, Bolton S, Dassie F, Francomano C, Marshall RP, Belal M, Skordilis K, Hayer M, Price AM, Cramb R, Edwards N, Steeds RP, Geberhiwot T. Defining renal phenotype in Alström syndrome. Nephrol Dial Transplant 2020;35:994-1001. [PMID: 30307515 DOI: 10.1093/ndt/gfy293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
40 Domínguez-Vías G, Segarra AB, Ramírez-Sánchez M, Prieto I. The Role of High Fat Diets and Liver Peptidase Activity in the Development of Obesity and Insulin Resistance in Wistar Rats. Nutrients 2020;12:E636. [PMID: 32121057 DOI: 10.3390/nu12030636] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]